Endoscopy 2019; 51(05): E111-E112
DOI: 10.1055/a-0842-6287
E-Videos
© Georg Thieme Verlag KG Stuttgart · New York

Novel use of a cardiac septal occluder to treat a chronic recalcitrant bariatric fistula after Roux-en-Y gastric bypass

Diogo Turiani Hourneaux de Moura
1   Gastrointestinal Endoscopy Unit, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
2   Division of Gastroenterology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, United States
,
Igor Braga Ribeiro
1   Gastrointestinal Endoscopy Unit, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
,
Mateus Pereira Funari
1   Gastrointestinal Endoscopy Unit, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
,
Alberto Baptista
3   Department of Endoscopy, Hospital de Clinicas Caracas, San Bernardino, Venezuela
,
Christopher C. Thompson
2   Division of Gastroenterology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, United States
,
Eduardo Guimarães Hourneaux de Moura
1   Gastrointestinal Endoscopy Unit, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
› Author Affiliations
Further Information

Publication History

Publication Date:
21 February 2019 (online)

Although considered the gold standard for the treatment of obesity, bariatric surgeries are not free of complications. Fistulas occur after Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy in up to 8.3 % and 7 % of patients, respectively [1] [2]. We describe the first report of the off-label use of the cardiac septal occluder (AMPLATZER Septal Occluder; Abbott, St. Paul, Minnesota, USA) for the treatment of a chronic bariatric fistula ([Video 1]).

Video 1 Off-label use of the cardiac septal occluder (AMPLATZER Septal Occluder; Abbott, St. Paul, Minnesota, USA) for the treatment of chronic fistula after bariatric surgery with Roux-en-Y gastric bypass. After 15 days, the cutaneous ostium was closed completely. The patient remained asymptomatic at the 3-month follow-up. The cardiac septal occluder device appears to be effective and safe in the treatment of chronic bariatric fistulas. It seems to be an option mainly after conventional therapies have failed.


Quality:

A 33-year-old man with grade II obesity underwent RYGB. After 1 week, the patient was admitted with abdominal pain and fever. Computed tomography scan diagnosed a gastric pouch leak associated with intra-abdominal collections ([Fig. 1]). Emergency surgery was indicated, a peri-gastric collection associated with a gastric pouch leak was confirmed, and placement of two abdominal drains was performed, followed by admission to the intensive care unit.

Zoom Image
Fig. 1 Computed tomography with evidence of free fluid and abdominal collection.

After 25 days, the drain output was 300 mL/day, and an upper endoscopy showed a 20-mm leak in the gastric pouch in the topography of the superior staple line, just below the esophagogastric junction ([Fig. 2]). An esophageal fully covered metal stent (Hanaro, 16 cm × 22 mm; Micro Tech Co. Ltd., Anseong-Si, South Korea) was placed ([Fig. 3]). The stent was fixed with the Shin technique to avoid migration [3].

Zoom Image
Fig. 2 Endoscopic view of the fistulous orifice.
Zoom Image
Fig. 3 Radiological image demonstrating absence of contrast leakage after placement of a fully covered self-expandable metal stent. The first (proximal) clip indicates the fistulous orifice and the second indicates the gastrojejunal (distal) anastomosis.

After the stent placement, the drain output decreased to 30 mL/day. The stent was removed 4 weeks later because of patient intolerance. During the endoscopy, a chronic fistula (15 mm) with the external drain tube inside the orifice was observed. The drain was removed under direct endoscopic vision, until the endoscope was advanced to the skin. The fistula tract was noted to be fully epithelized.

As this chronic fistula remained unresponsive, placement of a cardiac septal occluder was performed ([Video 1], [Fig. 4]) [4] [5].

Zoom Image
Fig. 4 The septal cardiac occlude. a Endoscopic view. b Fluoroscopic view.

After 15 days, the cutaneous ostium was closed completely ([Fig. 5]). The patient remained asymptomatic at the 3-month follow-up.

Zoom Image
Fig. 5 Abdominal wall with complete closure of the two holes of the abdominal drains.


Endoscopy_UCTN_Code_TTT_1AO_2AI

Endoscopy E-Videos
https://eref.thieme.de/e-videos

Endoscopy E-Videos is a free access online section, reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high quality video and all contributions are freely accessible online.
This section has its own submission website at https://mc.manuscriptcentral.com/e-videos

 
  • References

  • 1 Ribeiro IB, Gestic MA, Utrini MP. et al. Drain amylase levels may indicate gastrojejunostomy leaks after Roux-en-Y gastric bypass. Arq Gastroenterol 2018; 55: 66-72
  • 2 Okazaki O, Bernardo WM, Brunaldi VO. et al. Efficacy and safety of stents in the treatment of fistula after bariatric surgery: a systematic review and meta-analysis. Obes Surg 2018; 28: 1788-1796
  • 3 Martins BC, Retes FA, Medrado BF. et al. Endoscopic management and prevention of migrated esophageal stents. World J Gastrointest Endosc 2014; 6: 49-54
  • 4 Repici A, Presbitero P, Carlino A. et al. First human case of esophagus-tracheal fistula closure by using a cardiac septal occluder (with video). Gastrointest Endosc 2010; 71: 867-869
  • 5 Melmed GY, Kar S, Geft I. et al. A new method for endoscopic closure of gastrocolonic fistula: novel application of a cardiac septal defect closure device (with video). Gastrointest Endosc 2009; 70: 542-845